spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare Industry NewsFeed

 HSMN NewsFeed - 4 Jan 2013
Inotek Pharmaceuticals Appoints David R. King as Executive Chairman
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 4 Jan 2013
Tim Mayleben Named President And CEO Of Esperion Therapeutics
Biopharmaceuticlas Personnel
 HSMN NewsFeed - 4 Jan 2013
Osmotica Pharmaceutical Announces the Appointment of Senior Industry Executive Praveen Tyle, Ph.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2013
InspireMD Names Alan Milinazzo President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 4 Jan 2013
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2013
Predictive Biosciences Appoints Diagnostics Industry Veteran Pierre Cassigneul as Chief Executive Officer
Diagnostics Oncology Urology Personnel
 HSMN NewsFeed - 4 Jan 2013
EndoChoice Expands Product Line With Revolutionary Endoscope Through Merger With Peer Medical
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 4 Jan 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 Jan 2013
Tensys Medical Receives US FDA 510(k) for TL-300, Latest Generation in Continuous, Non-Invasive Hemodynamic Patient Monitoring System
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 3 Jan 2013
Gradalis, Inc. Closes $24 Million in Series B Financing to Advance Late-Stage Trials of FANG(TM) Personalized Cancer Vaccine
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Jan 2013
Valeant Pharmaceuticals Announces New Management Appointment
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 3 Jan 2013
Angioslide Completes $6.3 Million Financing Led by TriVentures
Devices Interventional Venture Capital
 HSMN NewsFeed - 3 Jan 2013
Alphatec Spine Receives U.S. FDA 510(K) Market Clearance for Two New Products and Receives Japanese Shonin Approval to Begin Marketing Its Novel(R) Peek Lumbar Spinal Spacers
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 3 Jan 2013
Advaxis Appoints Daniel J. O'Connor to Senior Vice President, Chief Legal and Business Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2013
Biogen Idec Reports Top-Line Results from Phase 3 Trial Investigating Dexpramipexole in People with Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Jan 2013
NewLink Genetics Appoints Mr. Brian Wiley as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2013
Given Imaging Launches New ManoView(TM) ESO v3.0 Software
Devices Gastroenterology
 HSMN NewsFeed - 3 Jan 2013
Sensimed AG Receives a New Reimbursement Code in the USA by the AMA for Intraocular Pressure Monitoring
Devices Reimbursement Ophthalmology
 HSMN NewsFeed - 3 Jan 2013
Phase 3 DECISION Trial of Nexavar(R) (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jan 2013
Pernix Therapeutics Completes Acquisition of Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Jan 2013
Abbott Completes Separation of Research-Based Pharmaceuticals Business
Biopharmaceuticals
 HSMN NewsFeed - 2 Jan 2013
FDA Grants Soligenix Orphan Drug Designation for OrbeShield(TM) for Treatment after Exposure to a Radiological Disaster
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jan 2013
FDA Approves Fulyzaq(TM) (Crofelemer) 125 mg Delayed-Release Tablets for the Symptomatic Relief of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy (ART)
Biopharmaceuticals FDA HIV/AIDS
 HSMN NewsFeed - 2 Jan 2013
RaySearch Laboratories: RaySearch and Siemens dissolve partnership
Devices Oncology Licensing
 HSMN NewsFeed - 1 Jan 2013
DJO Global Acquires Exos Corporation
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 31 Dec 2012
FDA Grants Accelerated Approval for SIRTURO(TM) (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Dec 2012
Endologix IntuiTrak Delivery System Receives Shonin Approval for Marketing in Japan
Devices Interventional Regulatory
 HSMN NewsFeed - 31 Dec 2012
Medical Modeling Receives FDA 510(k) Clearance for VSP(R) (Virtual Surgical Planning) System
Devices Surgery FDA
 HSMN NewsFeed - 31 Dec 2012
novoGI Acquires an Exclusive License to Brand and Market a Next-Generation GI Endoscopic Video Processing Standalone Solution
Devices Gastroenterology Licensing
 HSMN NewsFeed - 30 Dec 2012
Mazor Robotics Announces Foundation Surgical Hospital of San Antonio Purchases its Renaissance System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 29 Dec 2012
Bristol-Myers Squibb and Pfizer Announce U.S. FDA Approval of ELIQUIS(R) (apixaban)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 28 Dec 2012
K-V Pharmaceutical Receives Court Approval of Hologic Settlement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 28 Dec 2012
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 28 Dec 2012
Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Intraoperative Neurophysical Monitoring Services
Devices Group Purchasing
 HSMN NewsFeed - 27 Dec 2012
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation
Diagnostics Personnel Personalized Medicine
 HSMN NewsFeed - 27 Dec 2012
Isotechnika Announces That Lux Biosciences' Phase 3 Uveitis Study Did Not Meet Primary Endpoint
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Dec 2012
U.S. Food and Drug Administration Accepts XIAFLEX(R) Supplemental Biologics License Application Filing for the Treatment of Peyronie's Disease
Biopharmaceuticals Urology
 HSMN NewsFeed - 26 Dec 2012
Amarantus BioScience Acquires Neurodegenerative Diagnostic Intellectual Property Portfolio from Power3 Medical Products
Biopharmaceuticals Diagnostics Neurology Acquisitions
 HSMN NewsFeed - 26 Dec 2012
ELIQUIS(R) (apixaban) Approved In Japan For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 26 Dec 2012
Covidien Announces Definitive Agreement to Acquire CV Ingenuity
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 24 Dec 2012
CorMedix Announces Changes in Executive Team
Biopharmaceuticals Personnel
More stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!